The Abu Dhabi Investment Office (ADIO) has announced it will expand its San Francisco office to support the global growth of Abu Dhabi’s economic sectors.
Situated in a hub for health tech, biotech, and venture capital, the expanded office will showcase Abu Dhabi’s rapid clinical validation and regulatory frameworks, positioning the emirate as a launchpad for global healthcare innovation and other priority industries.
In April 2025, ADIO and the Abu Dhabi Department of Economic Development (ADDED), in partnership with the Department of Health – Abu Dhabi, launched the Health, Endurance, Longevity and Medicine (HELM) cluster. They expect HELM to contribute US$25.6 billion to Abu Dhabi’s GDP, create 30,000 new jobs, and attract US$11.5 billion in investment by 2045.
The San Francisco office will focus on HELM, which aims to tap into the global healthcare market projected to reach US$25.3 trillion by 2045.
HELM stands out as one of the world’s largest health innovation programmes. It builds on Abu Dhabi’s expertise in genomics, population health insights, AI-driven healthcare, and adaptive regulations.
The ADIO team will help US-based startups and scale-ups expand to Abu Dhabi, joining firms like Insilico Medicine and Innovaccer that have already established a presence there.
ADIO made the announcement during a high-level delegation visit to San Francisco, led by Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi. The visit aimed to strengthen partnerships and engage with innovators, decision-makers, and institutions in health technology and innovation.
Ahmed Jasim Al Zaabi, Chairman of ADDED, said, “Our San Francisco office acts as more than a physical presence; it serves as a platform to match investments, enter new markets, and support long-term growth. By expanding, we open fresh opportunities within Abu Dhabi’s economy and build two-way bridges for capital, innovation, and impact across key sectors.”
